Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06205342 · ClinicalTrials.gov registry record · Early Phase 1
Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain
A Early Phase 1 study of Chronic Pain and Chronic Pancreatitis, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06205342: Recruiting Early Phase 1 study of Chronic Pain and Chronic Pancreatitis, sponsored by Medical University of South Carolina.
NCT06205342 is a Early Phase 1 study of Chronic Pain and Chronic Pancreatitis that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 48 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06205342, a Early Phase 1 study of Chronic Pain and Chronic Pancreatitis, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol aims to test whether an infusion of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) can reduce pain associated with chronic pancreatitis (CP) and explore potential mechanisms of MSC action.
Primary Outcome
Change in pain as measured by Izbicki pain scores, a validated score for pain in chronic pancreatitis, consist of 4 questions, with a range of 0 (no pain) to 100 (severe, debilitating pain).
Conditions Studied
Interventions
- OTHER Other: Placebo
- DRUG Mesenchymal Stem Cells
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-07-17 |
| Est. Completion | 2028-06-01 |
| Phase | Early Phase 1 |
What NCT06205342 shows while recruiting
NCT06205342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Other: Placebo is the first listed.
NCT06205342 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06205342 about?
NCT06205342 is a clinical study titled "Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain". This protocol aims to test whether an infusion of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) can reduce pain associated with chronic pancreatitis (CP) and explore potential mechanisms of MSC action.
What is the current status of trial NCT06205342?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2024-07-17. Estimated completion is 2028-06-01.
What conditions does trial NCT06205342 study?
This clinical trial studies the following conditions: Chronic Pain, Chronic Pancreatitis.
What interventions are being tested in trial NCT06205342?
The interventions under investigation include: Other: Placebo (OTHER), Mesenchymal Stem Cells (DRUG).
Who is sponsoring clinical trial NCT06205342?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06205342 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06205342's enrollment target sits among peer trials
48 202nd of 301 higher than 98 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cannabidiol in Opioid Use Disorder and Chronic Pain
RECRUITING · Early Phase 1
-
Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction
ACTIVE NOT RECRUITING · Early Phase 1
-
Immunologic Response to Negative Cognition in Persons With Chronic Pain
COMPLETED · Early Phase 1
-
Managing Chronic Pain in Veterans With Substance Use Disorders
COMPLETED · Early Phase 1
-
Non-Opioid Pramipexole and Pain
COMPLETED · Early Phase 1
-
Exploratory Evaluation of [11C]-NOP46
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI